XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2020
Dec. 25, 2019
Dec. 26, 2018
Cash flows from operating activities:      
Net income (loss) $ (5,116) $ 117,410 $ 43,693
Adjustments to reconcile net income (loss) to cash flows provided by (used in) operating activities:      
Depreciation and amortization 16,161 19,846 27,039
Operating (gains), losses and other charges, net 1,808 (91,180) 2,620
Gains (losses) on interest rate swap derivatives, net (2,164) 0 0
Amortization of deferred financing costs 876 608 607
Gains on investments (123) (180) (9)
(Gains) losses on early extinguishments of debt and leases 224 (4) (171)
Deferred income tax expense 3,981 16,005 6,193
Increase (decrease) of tax valuation allowance (3,041) (2,935) 121
Share-based compensation 7,948 6,694 6,038
Changes in assets and liabilities:      
Receivables 6,378 (2,030) (4,722)
Inventories 101 1,668 141
Prepaids and other current assets (3,872) (4,108) 921
Other assets (1,816) (4,581) 2
Operating lease assets/liabilities 844 (601) 0
Accounts payable (10,682) (5,170) (5,147)
Accrued salaries and vacations (2,835) (3,826) 2,175
Accrued taxes (774) (2,043) 283
Other accrued liabilities (5,525) (4,144) (1,676)
Other noncurrent liabilities (5,510) 1,898 (4,418)
Net cash flows provided by (used in) operating activities (3,137) 43,327 73,690
Cash flows from investing activities:      
Capital expenditures (6,962) (13,975) (22,025)
Acquisition of restaurants and real estate 0 (11,320) (10,416)
Proceeds from disposition of property 9,398 129,721 3,052
Investment purchases (1,400) (1,760) (1,700)
Proceeds from sale of investments 2,900 0 0
Collections on notes receivable 1,814 3,654 2,740
Issuance of notes receivable (1,099) (1,351) (3,668)
Net cash flows provided by (used in) investing activities 4,651 104,969 (32,017)
Cash flows from financing activities:      
Revolver borrowings 140,500 164,400 136,000
Revolver payments (170,500) (210,900) (108,500)
Long-term debt payments (1,570) (2,464) (3,181)
Tax withholding on share-based payments (4,331) (3,206) (1,714)
Deferred financing costs (1,758) 0 0
Purchase of treasury stock (36,008) (94,459) (61,237)
Purchase of equity forward contract 0 0 (6,763)
Proceeds from issuance of common stock 69,571 0 0
Proceeds from exercise of stock options 427 971 1,225
Net bank overdrafts 2,675 (4,292) 2,540
Net cash flows used in financing activities (994) (149,950) (41,630)
Increase (decrease) in cash and cash equivalents 520 (1,654) 43
Cash and cash equivalents at beginning of period 3,372 5,026 4,983
Cash and cash equivalents at end of period $ 3,892 $ 3,372 $ 5,026